Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
1. Dual inhibitor of XO / URAT1, Orally-active, the inhibitory activity of URAT1 is better than that of benzbromarone.
(1) Xanthine Oxidase (XO) Inhibitor
Xanthine oxidase (XO) is a critical enzyme in the metabolism of purines to uric acid. Effective urate lowering via xanthine oxidase inhibition therapy is associated with a high risk of gout flares at the start of therapy.
(2) Urate transporter 1 (URAT1) Inhibitor
Urate transporter 1 (URAT1) is a major protein involved in uric acid reabsorption (about 90%). URAT1 inhibitors are thought to be a highly effective and promising class of uricosuric agents for treating hyperuricemia.
2. Good efficacy and safety in the preclinical study.
(1) No toxicity was observed in the preclinical study.
(2) Therapeutic effect in black-capped monkeys:
The results of in vivo efficacy experiments showed that：
a) Asset dose-dependently increases the amount of xanthine and hypoxanthine in blood, and inhibits XO activity.
b) Asset dose-dependently promotes renal uric acid excretion and inhibits URAT1 activity.
1. Asset type: XO/URAT1 Dual target inhibitors
2. Indication: Hyperuricemia (HUA)
3. Modality: Small molecular
4. Research phase: Phase 1 is ongoing in China
5. Patent: granted in CN and the US (2036)
6. Cooperation demands: License-out or co-development
7. Research progress：
(1) Phase 1 trial in China.
(2) Patent has been granted in both CN and the US.
(3) Inhibitory effect on uric acid was shown in black-capped monkeys.
Explore our catalog of therapeutic antibody solutions to find the right products for you! We are dedicated to delivering solutions designed to help you drive innovation and push the boundaries of what therapeutic antibodies can be.
Organoid Toolbox is a collection of organoid solutions including ready-to-use organoids, organoid differentiation kits, and a variety of services to accelerate the progress of your drug development project.
To enable antibody characterization methodsACROBiosystems has developed a series of enzymes.such as ldeS, SpeB, EndoH, and Endo S proteases, toassist with the characterization of antibodies and theirrelated post-translational modifications (PTMs)
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2， CD133, GPRC5D，CCR8, CCR5, etc.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
Comprehensive cytokine targets including interleukins, growth factors, chemokines, TNFs, etc. are expressed by HEK293 to ensure their natural structure. Their high purity is verified by SDS-PAGE/HPLC/SEC-MALS and high bioactivity is verified by ELISA/SPR/BLI.
Aneuro provides innovative solutions for neuroscience research. Recombinant proteins, neural factors, pre-formed fibrils, electrophysiological electrodes, as well as Organoid Toolbox all in Aneuro aiming to advance neuroscience research, develop therapeutic interventions, and improve diagnostic methods for neurological diseases.
This web search service is supported by Google Inc.
A-Z
